Revenue from operations was at ₹767.5 crore, 12.7% higher than ₹681 crore reported in the March quarter of FY24
RBI noticed that Union Bank did not transfer the eligible unclaimed amounts to the DEAF within the prescribed time, violating the rules in force.
Annual income at the company also grew by a big margin of ₹31,724 crore in FY25 from ₹29,002 crore in FY24, up 9.4% on yearly basis
Its operating revenue in the quarter also stayed nearly flat at ₹2,055 crore as against ₹2,110 crore in Q4 FY24
An EBITDA of ₹498 crore at Q4 FY25 shrank by 6.4% over ₹532.2 crore in the corresponding quarter last year.
Revenue from operations was down by 20.3% y-o-y to ₹1,360.9 crore in Q4 FY25 from ₹1,708.2 crore in Q4 FY24
Gangwal and The Chinkerpoo Family Trust will offload the stake at a floor price of ₹5,175 per share.
Domestic patient volumes rose over 15% year-on-year in the March quarter, helping to offset a sharp 53% decline in medical tourism from Bangladesh
Its net profit for FY 25 rose over threefold to ₹608.33 crore, against ₹181.05 crore in FY24
Here are some of the stocks that may see significant price movement today: Lupin, IndiGo, Nazara Tech, Aurobindo Pharma, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
